Medikamentöse antivirale und immunmodulatorischeTherapie


Originalarbeit: Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results, preprint 15.10.2020

Originalarbeit: Remdesivir for the Treatment of Covid-19 — Final Report, NEJM 08.10.2020

Meta-Analyse: Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19A Meta-analysis, JAMA 02.09.2020

Originalarbeit: Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19, JAMA 21.08.2020

Originalarbeit: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report, NEJM 17.07.2020

Positionspapier: Therapie mit Dexamethason bei Patienten mit COVID-19, DGP 01.07.2020

Originalarbeit: Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19A Randomized Clinical Trial, JAMA 03.06.2020

Originalarbeit: Postexposure Hydroxychloroquine Does Not Prevent COVID-19, NEJM 03.06.2020

Originalarbeit: Cardiovascular Toxicities Associated with Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database, Circulation 22.05.2020

Originalarbeit: Remdesivir for the Treatment of Covid-19 — Preliminary Report, NEJM 22.05.2020

Originalarbeit: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial, Lancet 08.05.2020

Originalarbeit: Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19, NEJM 14.05.2020

Originalarbiet: A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19, NEJM 07.05.2020

Originalarbeit: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial, Lancet 29.04.2020

Originalarbeit: Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, JAMA 24.04.2020

Originalarbeit: Compassionate Use of Remdesivir for Patients with Severe Covid-19, NEJM 10.04.2020

Editorial: Convalescent Plasma to Treat COVID-19 Possibilities and Challenges, JAMA 27.03.2020

Originalarbeit: Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma, JAMA 27.03.2020

Originalarbeit: A Trial of Lopinavir/Ritonavir in Adults Hospitalized with Severe Covid-19, NEJM 18.03.2020


Fachinformation: Lopinavir/Ritonavir (Kaletra®)

Fachinformation: Hydroxychloroquin (Quensyl®)